|
"hsu jd"的相關文件
顯示項目 1-25 / 55 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2020 |
Mulberry supplementation reduces lipid deposition and protects hamster retina from oxLDL damage
|
Wu, CS; Chung, TJ; Lee, YJ; Hsu, JD; Lee, HJ |
| 中山醫學大學 |
2013 |
Decreased Kruppel-like factor 4 (KLF4) expression may correlate with poor survival in gastric adenocarcinoma.
|
Hsu, LS; Chan, CP; Chen, CJ; Lin, SH; Lai, MT; Hsu, JD; Yeh, KT; Soon, MS |
| 中山醫學大學 |
2013 |
Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice.
|
Tsai, CC; Chiu, CC; Hsu, JD; Hsu, HS; Tzang, BS; Hsu, TC |
| 中山醫學大學 |
2012 |
Curcumin alleviates eosinophilic meningitis through reduction of eosinophil count following albendazole treatment against Angiostrongylus cantonensis in mice.
|
Shyu, LY; Chang, HH; Hsu, JD; Lin, DP; Teng, YH; Lee, HH |
| 中山醫學大學 |
2012 |
High incidence of acute promyelocytic leukemia specifically induced by N-nitroso-N-methylurea (NMU) in Sprague-Dawley rats.
|
Chang, YC; Hsu, JD; Lin, WL; Lee, YJ; Wang, CJ |
| 中山醫學大學 |
2012 |
Curcumin alleviates eosinophilic meningitis through reduction of eosinophil count following albendazole treatment against Angiostrongylus cantonensis in mice.
|
Shyu, LY; Chang, HH; Hsu, JD; Lin, DP; Teng, YH; Lee, HH |
| 國家衛生研究院 |
2011-01 |
Inhibitory effect of whole oat on aberrant crypt foci formation and colon tumor growth in ICR and BALB/c mice
|
Wang, HC;Hung, CH;Hsu, JD;Yang, MY;Wang, SJ;Wang, CJ |
| 中山醫學大學 |
2011 |
Expression of Krűppel-like factor 5 in gastric cancer and its clinical correlation in Taiwan.
|
Soon, MS; Hsu, LS; Chen, CJ; Chu, PY; Liou, JH; Lin, SH; Hsu, JD; Yeh, KT |
| 中山醫學大學 |
2011 |
Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein.
|
Tzang, BS; Lin, TM; Tsai, CC; Hsu, JD; Yang, LC; Hsu, TC |
| 中山醫學大學 |
2011 |
Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo.
|
Ou, TT; Wu, CH; Hsu, JD; Chyau, CC; Lee, HJ; Wang, CJ |
| 中山醫學大學 |
2011 |
Gallic acid induces G2/M phase arrest of breast cancer cell MCF-7 through stabilization of p27(Kip1) attributed to disruption of p27(Kip1)/Skp2 complex.
|
Hsu, JD; Kao, SH; Ou, TT; Chen, YJ; Li, YJ; Wang, CJ |
| 中山醫學大學 |
2010 |
Anti-cytokeratin CAM 5.2 is specific for K8 and to a lesser extent for the closely related K7, but shows no reactivity with K18 or K19: comment on: "keratin expression in endocrine organs and their neoplasms" Endocr Pathol.
|
Chen PJ;Hsu JD;Han CP |
| 中山醫學大學 |
2010 |
Aqueous extract of Hibiscus sabdariffa L. decelerates acetaminophen-induced acute liver damage by reducing cell death and oxidative stress in mouse experimental models.
|
Liu, LC; Wang, CJ; Lee, CC; Su, SC; Chen, HL; Hsu, JD; Lee, HJ |
| 中山醫學大學 |
2010 |
Anti-cytokeratin CAM5.2 reagent (Becton Dickinson Biosciences) can detect CK 8, not CK8/18-Comment on "Sonographic findings in a patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor," J Clin Ultrasound 2010 Jan 20 [Epub ahead of print].
|
Chen, PJ; Hsu, JD; Han, CP |
| 中山醫學大學 |
2010 |
HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target.
|
Han, CP; Hsu, JD; Yao, CC; Lee, MY; Ruan, A; Tyan, YS; Yang, SF; Chiang, H |
| 中山醫學大學 |
2010 |
EP4 upregulation of Ras signaling and feedback regulation of Ras in human colon tissues and cancer cells.
|
Wu, CH; Shih, YW; Chang, CH; Ou, TT; Huang, CC; Hsu, JD; Wang, CJ |
| 中山醫學大學 |
2010 |
The murine monoclonal antibody anti-cytokeratin CAM 5.2 is specific for intracellular cytokeratin 8, not cytokeratin 18.
|
Cheng, WC; Hsu, JD; Yao, CC; Han, CP |
| 中山醫學大學 |
2010 |
Becton Dickinson Biosciences CAM5.2 does not stand for true CK8/18. Comment on "Peripheral ameloblastoma in-situ: an evidential fact of surface epithelium origin", Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:763-7.
|
Wu, YL; Huang, YF; Hsu, JD; Han, CP |
| 中山醫學大學 |
2010 |
Anti-Cytokeratin CAM5.2 (BD) does not act as a substitute of the CK8/18 monoclonal antibody. Comment on: 'Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma'. Histopathology 2009; 54; 607-613.
|
Hsu, JD; Yao, CC; Yuan, CC; Lai, CR; Ting, LT; Li, YJ; Han, CP |
| 中山醫學大學 |
2010 |
BD (Becton, Dickinson and Company) Biosciences manufactures anticytokeratin CAM5.2, not CK8/18 monoclonal antibody.
|
Liao, CL; Tzeng, SL; Hsu, JD; Chen, PJ; Han, CP |
| 中山醫學大學 |
2010 |
True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
|
Hsu, JD; Yao, CC; Lee, MY; Kok, LF; Wang, PH; Tyan, YS; Han, CP |
| 中山醫學大學 |
2010 |
Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?
|
Liao, CL; Hsu, JD; Lee, MY; Kok, LF; Li, YJ; Wang, PH; Yao, CC; Han, CP |
| 中山醫學大學 |
2010 |
Antibody to cytokeratin (CK8/CK18) is not derived from CAM5.2 clone, and anticytokeratin CAM5.2 (Becton Dickinson) is not synonymous with the antibody (CK8/CK18).
|
Han, CP; Hsu, JD; Koo, CL; Yang, SF |
| 中山醫學大學 |
2010 |
Anticytokeratin CAM5.2 is not synonymous with CK8/18 monoclonal antibody; and anticytokeratin CAM5.2 can be a marker for cytokeratin 8 but not for cytokeratin 18 and 19.
|
Han, CP; Hsu, JD; Li, YJ |
| 中山醫學大學 |
2010 |
Anti-cytokeratin CAM5.2 is not a monoclonal antibody against cytokeratin 8/18.
|
Hsu, JD; Yao, CC; Han, LW; Han, CP |
顯示項目 1-25 / 55 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
